Gilead’s Lenacapavir Access Strategy in R...

By João L. Carapinha

October 14, 2024

Gilead Sciences, Inc. has announced important initiatives to increase access to lenacapavir, a potentially transformative HIV medication
Iraq Roche Partnership to Enhance Healthcare Services
FDA’s Opdivo Lung Cancer Approval
Boosting HPV Cervical Cancer Awareness: Key Insights on Public Survey
Enhancing Global Health through Regulatory Collaboration
The Trump Drug Policy Change: A Reverse Course
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
Artificial Intelligence in Elderly Care: Ethical and Responsible Adoption
NICE Recommends Abaloparatide for Osteoporosis in the Elderly
Elderly Technology Acceptance: Enhancing Health and Independence
New Innovations in Elderly Healthcare: Latest PBAC Outcomes
Caring for an Ageing US Population: Challenges and Innovations
ABRE Study: Optimising Treatment for Iliofemoral Venous Obstruction